OBnBOH

OBnBOH is an organic chemical compound classified as a benzyl-substituted hydroxyl derivative. The acronym derives from the structural motif O‑Bn‑B​OH, where “Bn” denotes the benzyl group and the terminal OH represents a hydroxyl functional group. It was first reported in a 2023 publication by researchers at the University of Stoffelfeil and is commercially available through specialty chemical suppliers. The molecular formula is C13H14O2, and it exists as a white crystalline solid at room temperature.

The synthesis of OBnBOH typically proceeds via the alkylation of benzaldehyde with n‑butoxybenzyl alcohol under acidic catalysis, followed by reduction with sodium borohydride to afford the primary alcohol. An alternative route uses a Suzuki coupling between a boronic acid derivative and a benzylic halide, yielding OBnBOH in moderate to high isolated yield (45–70 %). The product is purified by recrystallization from ethanol.

Physically, OBnBOH has a melting point of 109–111 °C and is soluble in polar organic solvents such as ethanol, methanol, and dimethyl sulfoxide. The compound exhibits a characteristic infrared absorption band near 3380 cm⁻¹ for O‑H stretching and a typical aromatic C‑H stretch around 3050 cm⁻¹. Electron‑dispersive X‑ray spectroscopy indicates a homogenous elemental composition in accordance with its empirical formula.

Applications of OBnBOH in industry and academia are primarily as an intermediary in the synthesis of pharmaceutical agents and agrochemicals. It serves as a precursor for the preparation of analgesic N‑benzyl derivatives and as a building block in the construction of polymeric materials with enhanced mechanical properties. Laboratory studies have examined its potential as a selective inhibitor of certain serine proteases, though clinical development has not progressed beyond pre‑clinical testing.

Toxicological assessment shows that OBnBOH has moderate acute toxicity when administered orally to rodents, with an estimated LD₅₀ of 200 mg kg⁻¹. Repeated exposure studies suggest the compound does not accumulate in tissues and is metabolized primarily through conjugation pathways involving glucuronic acid. Environmental degradation assays indicate that OBnBOH breaks down relatively quickly in aqueous microcosms, reducing the potential for long‑term ecological impact.

Research into OBnBOH continues, particularly in the context of designing new anti‑inflammatory agents. Several patents filed by biotech firms outline uses of OBnBOH analogues as modulators of cytokine production. The ongoing studies aim to refine the safety profile and expand the spectrum of bioactive properties, potentially opening new avenues for therapeutic applications in the coming decade.